The First Trust NYSE Arca Biotechnology ETF (FBT) was launched on 06/19/2006, and is a smart beta exchange traded fund designed to offer broad exposure to the Health Care ETFs category of the market.

For the First Trust NYSE Arca Biotechnology Index Fund ETF (Symbol: FBT), we found that the implied analyst target price for the ETF based upon its underlying holdings is $218.78 per unit.

If you're interested in broad exposure to the Healthcare - Biotech segment of the equity market, look no further than the First Trust NYSE Arca Biotechnology ETF (FBT), a passively managed ...

First Trust NYSE Arca Biotech Fund earns a Below Average Process Pillar rating. Morningstar's algorithmically assigned Passive Process ratings are first formulated by comparing the historical ...

Detailed price information for First Trust NYSE Arca Biotechnology ETF (FBT-T) from The Globe and Mail including charting and trades.

First Trust Arca Biotechnology Ucits Etf is listed on the Euronext Milan trading with ticker code FBT.MI. It has a market capitalisation of €1.89m, with approximately 100.00k shares in issue.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...